Ken Griffin Agilent Technologies, Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$128.12 - $149.31 $4.14 Million - $4.82 Million	-32,300 Reduced 14.5%	190,500 $27.7 Million
Q4 2023 Feb 14, 2024	BUY	$101.17 - $139.82 $3.58 Million - $4.95 Million	35,400 Added 18.89%	222,800 $31 Million
Q3 2023 Nov 14, 2023	BUY	$109.73 - $128.47 $1.79 Million - $2.09 Million	16,300 Added 9.53%	187,400 $21 Million
Q2 2023 Aug 14, 2023	BUY	$114.69 - $141.28 $5.09 Million - $6.27 Million	44,400 Added 35.04%	171,100 $20.6 Million
Q1 2023 May 15, 2023	SELL	$131.13 - $159.06 $5.85 Million - $7.09 Million	-44,600 Reduced 26.04%	126,700 $17.5 Million

Q4 2022 Feb 14, 2023	SELL	$125.64 - $157.68 $5.88 Million - $7.38 Million	-46,800 Reduced 21.46%	171,300 $25.6 Million
Q3 2022 Nov 14, 2022	SELL	$115.11 - $142.29 $13.7 Million - $16.9 Million	-118,800 Reduced 35.26%	218,100 $26.5 Million

1,090

262M

912K

777K

Ticker A
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 296,040,992
Market Cap $37.2B
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.